Kopran has received Certificate of Compliance with principles and guidelines of Good Manufacturing Practice from United Kingdom, Medicines and Healthcare products Regulatory Agency (UKMHRA) for the Finished Dosage Forms facility located at Savroli, Khalapur, Khopoli manufacturing general capsules arid tablets. The approval for this facility shall enable the Company to supply Finished Dosage Forms to the UK and the European market for which necessary marketing tie-ups are being entered into.
The facility also has approvals from Regulatory Authorities of several countries all over the world including the Medicines Control Council, South Africa (MCC) and the Therapeutic Goods Administration, Australia (TGA).
Kopran is the group company of Parijat Enterprises. Kopran is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.
